Weekly nanoparticle albumin-bound paclitaxel in combination with cisplatin versus weekly solvent-based paclitaxel plus cisplatin as first-line therapy in Chinese patients with adva...

por Wang, Hai-ying, Yao, Zhi-hua, Tang, Hong, Zhao, Yan, Zhang, Xiao-san, Yao, Shu-na, Yang, Shu-jun, Liu, Yan-yan
Publicado 2016

A retrospective clinical study of comparing paclitaxel plus S-1 versus paclitaxel plus cisplatin as the first-line treatment for patients with advanced esophageal squamous cell car...

por Wang, Hai-ying, Yao, Zhi-hua, Tang, Hong, Zhao, Yan, Jin, Shui-ling, Zhou, Wen-ping, Yao, Shu-na, Yang, Shu-jun, Liu, Yan-yan, Luo, Su-xia
Publicado 2016

Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced oesophageal squamous cell carcinoma: a single-Centre, open-label, randomized, controlled, clinica...

por Sun, Hai-Bo, Xing, Wen-Qun, Liu, Xian-Ben, Zheng, Yan, Yang, Shu-Jun, Wang, Zong-Fei, Liu, Shi-Lei, Ba, Yu-Feng, Zhang, Rui-Xiang, Liu, Bao-Xing, Fan, Cheng-Cheng, Chen, Pei-Nan, Liang, Guang-Hui, Yu, Yong-Kui, Liu, Qi, Wang, Hao-Ran, Li, Hao-Miao, Li, Zhen-Xuan
Publicado 2020

Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02)

por Wang, Feng-Hua, Wei, Xiao-Li, Feng, Jifeng, Li, Qi, Xu, Nong, Hu, Xi-Chun, Liao, Wangjun, Jiang, Yi, Lin, Xiao-Yan, Zhang, Qing-yuan, Yuan, Xiang-Lin, Huang, Hai-Xin, Chen, Ye, Dai, Guang-Hai, Shi, Jian-Hua, Shen, Lin, Yang, Shu-Jun, Shu, Yong-Qian, Liu, Yun-Peng, Wang, Weifeng, Wu, Hai, Feng, Hui, Yao, Sheng, Xu, Rui-Hua
Publicado 2021